| A | Aorta |
| ACPAs | Anti-citrullinated peptide antibodies |
| ADM | Amyopathic dermatomyositis |
| AIP | Acute interstitial pneumonia |
| ALAT | Latin American Thoracic Association |
| Anti-MDA5 | Anti-melanoma differentiation-associated gene 5 |
| ARS | Aminoacyl-transfer RNA synthetases |
| ASyS | Antisynthetase syndrome |
| ATS | American Thoracic Society |
| AUL | Anterior Upper Lobe |
| BALT | Bronchus-associated lymphoid tissue |
| BNP | Brain natriuretic peptide |
| BSR | British Society for Rheumatology, |
| CB | Constrictive bronchiolitis |
| COP | Cryptogenic organizing pneumonia |
| CRP | C-reactive protein |
| CTD-ILDs | Connective tissue disease associated interstitial lung disease |
| CTDs | Connective tissue diseases |
| DAD | Diffuse alveolar damage |
| DLCO | Diffusion capacity for carbon monoxide |
| DM | Dermatomyositis |
| EHC | Exuberant Honeycombing |
| ERS | European Respiratory Society |
| ESR | Erythrocyte sedimentation rate |
| ESSDAI | EULAR Sjögren’s syndrome disease activity index |
| FB | Follicular bronchiolitis |
| FVC | Forced vital capacity |
| GGO | Ground-glass opacities |
| HP | Histopathological |
| HRCT | High-resolution computed tomography |
| IIMs | Idiopathic Inflammatory Myopathies |
| ILD | Interstitial lung disease |
| IMNM | Immune-mediated necrotizing myopathy |
| iNSIP | Idiopathic NSIP |
| IPF | Idiopathic pulmonary fibrosis |
| JRS | The Japanese Respiratory Society |
| lcSSc | Limited cutaneous SSc |
| LIP | Lymphoid interstitial pneumonia |
| MALT | Mucosa-associated lymphoid tissue |
| MCTD | Mixed Connective Tissue Disease |
| mMRC | Modified Medical Research Council |
| mPAP | Mean pulmonary arterial pressure |
| MSAs | Myositis-specific autoantibodies |
| NOS | Newcastle–Ottawa Scale |
| NSIP | Non-specific interstitial pneumonia |
| NT-proBNP | N-terminal pro brain natriuretic peptide |
| OP | Organizing pneumonia |
| PA | Pulmonary artery |
| PAH | Pulmonary arterial hypertension |
| PAWP | Pulmonary arterial wedge pressure |
| PFT | Pulmonary function tests |
| PM | Polymyositis |
| PRISMA | Preferred Reporting Items for Systematic Reviews and Meta-Analyses |
| pSS | Primary Sjögren’s syndrome |
| PVR | Pulmonary vascular resistance |
| RA | Rheumatoid Arthritis |
| RF | Rheumatoid factor |
| RHC | Right heart catheterization |
| RNP | Ribonucleoprotein |
| RP-ILD | Rapidly progressive interstitial lung disease |
| SE | Straight-Edge |
| sIBM | Sporadic inclusion-body myositis |
| SLE | Systemic Lupus Erythematosus |
| SS | Sjögren’s syndrome |
| SSc | Systemic Sclerosis |
| TGF-β | Transforming growth factor-beta |
| UIP | Usual interstitial pneumonia |
| WHO | The World Health Organization |